2025年核糖核酸（RNA）定序全球市場報告

預計未來幾年核糖核酸（RNA）定序市場規模將呈指數級成長。到 2029 年，這一數字將成長至 89.1 億美元，複合年成長率為 22.3%。預測期內的成長可歸因於對快速準確疾病診斷的需求不斷成長、即時聚合酵素鏈鎖反應的採用不斷增加、對快速現場診斷測試的需求不斷成長、感染疾病爆發數量的增加以及對伴同性診斷的需求。預測期內的關鍵趨勢包括疾病檢測和監測、藥物發現、目標檢驗、生物標記識別、DNA定序技術、診斷測試的進步、下一代定序（NGS）、微流體、實驗室晶片平台以及先進分子診斷解決方案的開發。

核糖核酸（RNA）定序市場的成長軌跡預計將受到精準醫療日益重視的推動。精準醫療，也稱為個人化醫療，是一種考慮到基因、環境和生活方式的個體差異的治療和預防創新方法。在基因組學進步、疾病複雜性增加和支持性監管措施的推動下，這種方法有望提供更有效的治療方法。 RNA序列測定技術在這方面發揮關鍵作用，可以對 RNA 分子序列測定並量化樣本中的表現量。這些技術有助於對轉錄組進行整體分析，從而深入了解基因表現模式、可變剪接事件和 RNA 修飾。值得注意的是，FDA 於 2024 年 2 月核准了16 種針對罕見疾病患者的新型個人化療法。因此，對精準醫療的日益關注正在推動核糖核酸 (RNA) 定序市場的擴張。

在核糖核酸 (RNA) 定序市場，主要企業正在優先考慮 RNA 下一代定序檢測，以透過資料主導的洞察和精準醫療來加強患者照護。 RNA 次世代定序檢測利用先進的基因組定序技術來分析患者的整個EXOME，並代表下一代EXOME定序平台。例如，美國精準醫療科技公司Tempus於2023年6月推出了新的獨立RNA次世代定序方法Tempus xR。這款創新檢測方法專為固體癌而設計，可對整個轉錄組進行全面分析，以識別100多個目標基因中具有臨床意義的融合以及MET外顯子14和EGFRvIII剪接改變。此檢測適用於對 RNA 融合和剪接改變有特殊興趣的醫生，以及尋求對現有樣本進行深入 RNA 定序分析的醫療保健提供者、研究人員和生物製藥公司。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球RNA定序PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 最終用途產業分析
• 全球核糖核酸（RNA）定序市場：成長率分析
• 全球核糖核酸（RNA）定序市場表現：規模與成長，2019-2024
• 全球核糖核酸 (RNA) 定序市場預測：規模與成長，2024-2029 年，2034 年
• 全球核糖核酸（RNA）定序總目標市場（TAM）

第6章市場區隔

• 全球核糖核酸（RNA）定序市場（依產品類型、效能和預測），2019-2024 年、2024-2029 年、2034 年
• 裝置
• 試劑和套件
• 軟體
• 全球核糖核酸（RNA）定序市場（依技術、效能和預測），2019-2024 年、2024-2029 年、2034 年
• 基於單分子的定序
• 序列雙合成技術
• 奈米孔定序技術
• Ion Torrent 半導體定序
• 全球核糖核酸（RNA）定序市場的應用、績效及預測（2019-2024年、2024-2029年及2034年）
• 診斷
• 藥物研發
• 轉換醫學
• 其他用途
• 全球核糖核酸 (RNA) 定序市場（依最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
• 研究與學術
• 醫院和診所
• 製藥和生物技術公司
• 其他最終用戶
• 全球核糖核酸（RNA）定序市場，按儀器類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
• 次世代定序儀
• 微陣列儀器
• 單細胞RNA定序儀
• 全球核糖核酸（RNA）定序市場試劑和套件盒細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
• RNA萃取試劑套件
• RNA定序套件
• 文庫製備試劑套件
• 全球核糖核酸（RNA）定序市場軟體細分（按類型、實際及預測），2019-2024 年、2024-2029 年、2034 年
• 資料分析軟體
• 資料管理軟體
• 生物資訊軟體

第7章 區域和國家分析

• 全球核糖核酸（RNA）定序市場：依地區、績效及預測，2019-2024年、2024-2029年、2034年
• 全球核糖核酸（RNA）定序市場：依國家、地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

• 核糖核酸（RNA）定序市場：競爭格局
• 核糖核酸（RNA）定序市場：公司簡介
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• GE HealthCare Technologies Inc
• Eurofins Scientific SE
• Agilent Technologies Inc
• Illumina Inc
• PerkinElmer Inc
• bioMerieux SA
• Beckman Coulter Inc
• Sysmex Corporation
• Bio-Rad Laboratories Inc
• QIAGEN NV
• Tecan Genomics Inc
• Natera Inc
• Myriad Genetics Inc.
• BGI Genomics Co Ltd
• Takara Bio Inc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029年核糖核酸（RNA）定序市場：提供新機會的國家
• 2029年核糖核酸（RNA）定序市場：細分領域帶來新機會
• 2029年核糖核酸（RNA）定序市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第36章 附錄

RNA sequencing, employing next-generation sequencing techniques, unveils the presence and abundance of RNA molecules within a biological specimen, offering a glimpse into gene expression dynamics. This methodology empowers scientists to delve into gene expression patterns, unearth novel transcripts, and decipher RNA processing mechanisms.

Within the realm of ribonucleic acid (RNA) sequencing, the primary product categories comprise instruments, reagents and kits, and software. Instruments encompass the tangible apparatuses utilized for RNA molecule analysis, encompassing sequencers and polymerase chain reaction devices, pivotal for accurate RNA sample processing and examination. Diverse technologies, including single molecule-based sequencing, sequence by synthesis, nanopore sequencing, and ion torrent semiconductor sequencing, find application across various sectors such as diagnostics, drug discovery, and translational medicine. End-users span research and academia, hospitals and clinics, pharmaceutical and biotechnology firms, among others.

The ribonucleic acid (RNA) sequencing market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (RNA) sequencing market statistics, including ribonucleic acid (RNA) sequencing industry global market size, regional shares, competitors with a ribonucleic acid (RNA) sequencing market share, detailed ribonucleic acid (RNA) sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (RNA) sequencing industry. This ribonucleic acid (RNA) sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ribonucleic acid (RNA) sequencing market size has grown exponentially in recent years. It will grow from $3.25 billion in 2024 to $3.98 billion in 2025 at a compound annual growth rate (CAGR) of 22.7%. The growth in the historic period can be attributed to rising number of drug development activities, growing prevalence of genetic disorders and target diseases, increasing use of miniaturized portable instruments, growing use of biomarker profiling, growing demand for personalized medicine, and the increasing number of cancer patients.

The ribonucleic acid (RNA) sequencing market size is expected to see exponential growth in the next few years. It will grow to $8.91 billion in 2029 at a compound annual growth rate (CAGR) of 22.3%. The growth in the forecast period can be attributed to rise in demand for rapid and accurate diagnosis of disease, growing adoption of real-time polymerase chain reaction, the growing demand for rapid and on-site diagnostic testing, rise in infectious disease outbreaks, and demand for companion diagnostics. Major trends in the forecast period include disease detection and monitoring, drug discovery, target validation, biomarker identification, DNA sequencing technologies, diagnostic testing advancements, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and advanced molecular diagnostic solutions development.

The growth trajectory of the ribonucleic acid (RNA) sequencing market is expected to be propelled by an increasing emphasis on precision medicine. Precision medicine, also known as personalized medicine, represents an innovative approach to medical treatment and prevention, taking into account individual variability in genes, environment, and lifestyle. This approach holds promise for offering more effective treatments, spurred by advancements in genomics, the rising complexity of diseases, and supportive regulatory measures. RNA sequencing technologies play a crucial role in this landscape, enabling the determination of RNA molecule sequences and quantification of their expression levels within samples. Such technologies facilitate comprehensive analysis of transcriptomes, offering insights into gene expression patterns, alternative splicing events, and RNA modifications. Notably, in February 2024, the FDA approved 16 novel personalized therapies for patients with rare diseases, compared to six approvals in 2022, as reported by the Personalized Medicine Coalition. Consequently, the growing focus on precision medicine serves as a driving force behind the ribonucleic acid (RNA) sequencing market's expansion.

In the ribonucleic acid (RNA) sequencing market, key players prioritize RNA next-generation sequencing assays to enhance patient care through data-driven insights and precision medicine. RNA next-generation sequencing assays leverage advanced genomic sequencing technologies to analyze a patient's entire exome, representing a next-generation exome sequencing platform. For example, in June 2023, Tempus, a US-based precision medicine technology company, introduced its new standalone RNA next-generation sequencing assay, Tempus xR. This innovative assay, tailored for solid tumors, provides a comprehensive analysis of the entire transcriptome, identifying clinically significant fusions in over 100 targeted genes and altered splicing for MET Exon 14 and EGFRvIII. This offering caters to physicians with specific interests in RNA fusions or altered splicing, as well as to providers, researchers, and biopharma companies seeking detailed RNA sequencing analysis for their existing samples.

In January 2024, Parse Biosciences, a US-based biotechnology company focusing on developing innovative solutions for biological research and diagnostics, completed the acquisition of Biomage for an undisclosed sum. This acquisition enables Parse Biosciences to integrate Biomage's robust data analysis tools, including its Cellenics cloud-based platform, into Parse's Evercode combinatorial barcoding technology. Biomage Ltd., based in the UK, specializes in RNA sequencing and analysis software and services.

Major companies operating in the ribonucleic acid (RNA) sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare Technologies Inc, Eurofins Scientific SE, Agilent Technologies Inc, Illumina Inc, PerkinElmer Inc, bioMerieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN N.V., Tecan Genomics Inc, Natera Inc, Myriad Genetics Inc., BGI Genomics Co Ltd, Takara Bio Inc, Cepheid, NeoGenomics Laboratories Inc, Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc, Macrogen Inc, Standard BioTools Inc, Ambry Genetics Corporation, Biocartis SA, CD Genomics.

North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ribonucleic acid (RNA) sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ribonucleic acid (RNA) sequencing market consists of revenues earned by entities by providing services such as library preparation, RNA extraction, fragmentation, reverse transcription, adapter ligation, sequencing, data analysis, bioinformatics support, consultation and experimental design, quality control, sample preparation services, gene cloning, genotyping and mutation detection, and pathogen detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The ribonucleic acid (RNA) sequencing market also includes sales of library preparation kits, RNA extraction kits, quantification kits, polymerase chain reaction (PCR) instruments, pipette tips, tubes, and plates. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ribonucleic Acid (RNA) Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ribonucleic acid (rna) sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ribonucleic acid (rna) sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ribonucleic acid (rna) sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Instruments; Reagents And Kits; Software
• 2) By Technology: Single Molecule Based Sequencing; Sequence By Synthesis Technology; Nanopore Sequencing Technology; Ion Torrent Semiconductor Sequencing
• 3) By Applications: Diagnostics; Drug Discovery; Translational Medicine; Other Applications
• 4) By End User: Research And Academia; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
• Subsegments:
• 1) By Instruments: Next-Generation Sequencers; Microarray Instruments; Single-Cell Rna Sequencing Instruments
• 2) By Reagents And Kits: Rna Extraction Kits; Rna Sequencing Kits; Library Preparation Kits
• 3) By Software: Data Analysis Software; Data Management Software; Bioinformatics Software
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Becton, Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ribonucleic Acid (RNA) Sequencing Market Characteristics

3. Ribonucleic Acid (RNA) Sequencing Market Trends And Strategies

4. Ribonucleic Acid (RNA) Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Ribonucleic Acid (RNA) Sequencing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Ribonucleic Acid (RNA) Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Ribonucleic Acid (RNA) Sequencing Market Growth Rate Analysis
• 5.4. Global Ribonucleic Acid (RNA) Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Ribonucleic Acid (RNA) Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Ribonucleic Acid (RNA) Sequencing Total Addressable Market (TAM)

6. Ribonucleic Acid (RNA) Sequencing Market Segmentation

• 6.1. Global Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Reagents And Kits
• Software
• 6.2. Global Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Molecule Based Sequencing
• Sequence By Synthesis Technology
• Nanopore Sequencing Technology
• Ion Torrent Semiconductor Sequencing
• 6.3. Global Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostics
• Drug Discovery
• Translational Medicine
• Other Applications
• 6.4. Global Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research And Academia
• Hospitals And Clinics
• Pharmaceutical And Biotechnology Companies
• Other End Users
• 6.5. Global Ribonucleic Acid (RNA) Sequencing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Next-Generation Sequencers
• Microarray Instruments
• Single-Cell Rna Sequencing Instruments
• 6.6. Global Ribonucleic Acid (RNA) Sequencing Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rna Extraction Kits
• Rna Sequencing Kits
• Library Preparation Kits
• 6.7. Global Ribonucleic Acid (RNA) Sequencing Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analysis Software
• Data Management Software
• Bioinformatics Software

7. Ribonucleic Acid (RNA) Sequencing Market Regional And Country Analysis

• 7.1. Global Ribonucleic Acid (RNA) Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Ribonucleic Acid (RNA) Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market

• 8.1. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ribonucleic Acid (RNA) Sequencing Market

• 9.1. China Ribonucleic Acid (RNA) Sequencing Market Overview
• 9.2. China Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ribonucleic Acid (RNA) Sequencing Market

• 10.1. India Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ribonucleic Acid (RNA) Sequencing Market

• 11.1. Japan Ribonucleic Acid (RNA) Sequencing Market Overview
• 11.2. Japan Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ribonucleic Acid (RNA) Sequencing Market

• 12.1. Australia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ribonucleic Acid (RNA) Sequencing Market

• 13.1. Indonesia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ribonucleic Acid (RNA) Sequencing Market

• 14.1. South Korea Ribonucleic Acid (RNA) Sequencing Market Overview
• 14.2. South Korea Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ribonucleic Acid (RNA) Sequencing Market

• 15.1. Western Europe Ribonucleic Acid (RNA) Sequencing Market Overview
• 15.2. Western Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ribonucleic Acid (RNA) Sequencing Market

• 16.1. UK Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ribonucleic Acid (RNA) Sequencing Market

• 17.1. Germany Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ribonucleic Acid (RNA) Sequencing Market

• 18.1. France Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ribonucleic Acid (RNA) Sequencing Market

• 19.1. Italy Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ribonucleic Acid (RNA) Sequencing Market

• 20.1. Spain Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market

• 21.1. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market Overview
• 21.2. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ribonucleic Acid (RNA) Sequencing Market

• 22.1. Russia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ribonucleic Acid (RNA) Sequencing Market

• 23.1. North America Ribonucleic Acid (RNA) Sequencing Market Overview
• 23.2. North America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ribonucleic Acid (RNA) Sequencing Market

• 24.1. USA Ribonucleic Acid (RNA) Sequencing Market Overview
• 24.2. USA Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ribonucleic Acid (RNA) Sequencing Market

• 25.1. Canada Ribonucleic Acid (RNA) Sequencing Market Overview
• 25.2. Canada Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ribonucleic Acid (RNA) Sequencing Market

• 26.1. South America Ribonucleic Acid (RNA) Sequencing Market Overview
• 26.2. South America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ribonucleic Acid (RNA) Sequencing Market

• 27.1. Brazil Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ribonucleic Acid (RNA) Sequencing Market

• 28.1. Middle East Ribonucleic Acid (RNA) Sequencing Market Overview
• 28.2. Middle East Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ribonucleic Acid (RNA) Sequencing Market

• 29.1. Africa Ribonucleic Acid (RNA) Sequencing Market Overview
• 29.2. Africa Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ribonucleic Acid (RNA) Sequencing Market Competitive Landscape And Company Profiles

• 30.1. Ribonucleic Acid (RNA) Sequencing Market Competitive Landscape
• 30.2. Ribonucleic Acid (RNA) Sequencing Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Ribonucleic Acid (RNA) Sequencing Market Other Major And Innovative Companies

• 31.1. GE HealthCare Technologies Inc
• 31.2. Eurofins Scientific SE
• 31.3. Agilent Technologies Inc
• 31.4. Illumina Inc
• 31.5. PerkinElmer Inc
• 31.6. bioMerieux SA
• 31.7. Beckman Coulter Inc
• 31.8. Sysmex Corporation
• 31.9. Bio-Rad Laboratories Inc
• 31.10. QIAGEN N.V.
• 31.11. Tecan Genomics Inc
• 31.12. Natera Inc
• 31.13. Myriad Genetics Inc.
• 31.14. BGI Genomics Co Ltd
• 31.15. Takara Bio Inc

32. Global Ribonucleic Acid (RNA) Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ribonucleic Acid (RNA) Sequencing Market

34. Recent Developments In The Ribonucleic Acid (RNA) Sequencing Market

35. Ribonucleic Acid (RNA) Sequencing Market High Potential Countries, Segments and Strategies

• 35.1 Ribonucleic Acid (RNA) Sequencing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Ribonucleic Acid (RNA) Sequencing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Ribonucleic Acid (RNA) Sequencing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer